ArticleTobacco control2018
Seven years of progress in tobacco control: an evaluation of the effect of nations meeting the highest level MPOWER measures between 2007 and 2014.
Article in Tobacco control, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Beyond MPOWER: a systematic review of population-level factors that affect European tobacco smoking rates.European journal of public health · 2023Pooled it
- Price elasticity of demand of non-cigarette tobacco products: a systematic review and meta-analysis.Tobacco control · 2018Pooled it
- Mediational Effects on Motivation to Quit Smoking After Exposure to a Cigarette Pictorial Warning Label Among Young Adults.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2022Trial
- Association between cigarette tax and the global burden of non-communicable diseases: a longitudinal ecological study in 193 countries.BMJ global health · 2026Article
- Exploring a Road Map to Achieving Tobacco Endgame in sub-Saharan Africa: A Qualitative Study Among Stakeholders From 12 Countries.Global health, science and practice · 2026Article
- Tobacco-Attributable Burden of Early-Onset Ischemic Heart Disease From 1990 to 2023: A Global Analysis Using GBD 2023 and Age-Period-Cohort Modeling.Clinical cardiology · 2026Article
- Evidence-based opportunities to address pandemic drivers via the Pandemic Agreement: lessons from the Framework Convention on Tobacco Control.BMJ global health · 2025Article
- Temporal trends in cardiovascular disease risk factors attributed burden in Iran, 1990-2021.Scientific reports · 2025Article
- Impact of tobacco exposure on global deaths of digestive diseases: Findings from 1990-2021 and projected trends to 2042.Tobacco induced diseases · 2025Article
- Global smoking-related deaths averted due to MPOWER policies implemented at the highest level between 2007 and 2020.Globalization and health · 2024Article
- Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan.Tobacco control · 2024Article
- Lung Disease and Social Justice: Chronic Obstructive Pulmonary Disease as a Manifestation of Structural Violence.American journal of respiratory and critical care medicine · 2024Article
- Tobacco control policies implementation and future lung cancer incidence in Saudi Arabia. A population-based study.Preventive medicine reports · 2023Article
- The knowledge, attitudes and behaviors of hospital nurses on smoking cessation interventions: a cross-sectional study.BMC nursing · 2023Article
- A comprehensive review on triple R eco-management strategies to reduce, reuse and recycle of hazardous cigarette butts.Heliyon · 2023Review
- Exposure of 4-year to 24-year olds to tobacco imagery on prime-time Chilean television.Tobacco control · 2023Article
- Summary and Concluding Remarks: Patterns of Birth Cohort‒Specific Smoking Histories.American journal of preventive medicine · 2023Article
- The Effects of Oral Nicotine Pouch Packaging Features on Adult Tobacco Users' and Non-Users' Product Perceptions.International journal of environmental research and public health · 2023Article
- Retailer's Density and Single Stick Cigarette's Accessibility among School-Age Children in Indonesia.Asian Pacific journal of cancer prevention : APJCP · 2023Article
- Global Implementation of Tobacco Demand Reduction Measures Specified in Framework Convention on Tobacco Control.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveSince WHO released the package of six MPOWER measures to assist nations with implementing the WHO Framework Convention for Tobacco Control (FCTC), 88 countries adopted at least one highest level MPOWER measure. We estimated the subsequent reduction in smoking-related deaths from all new highest level measures adopted between 2007 and 2014.
methodsPolicy effect sizes based on previously validated
findingsIn total, 88 countries adopted at least one highest level MPOWER policy between 2007 and 2014, resulting in almost 22 million fewer projected SADs. The largest number of future SADs averted was due to increased cigarette taxes (7.0 million), followed by comprehensive smoke-free laws (5.4 million), large graphic health warnings (4.1 million), comprehensive marketing bans (3.8 million) and comprehensive cessation interventions (1.5 million).
conclusionsThese findings demonstrate the immense public health impact of tobacco control policies adopted globally since the WHO-FCTC and highlight the importance of more countries adopting highest level MPOWER measures to reduce the global burden of tobacco use. Substantial additional progress could be made, especially if heavily populated nations with high smoking prevalence were to reach highest level MPOWER measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.